Global Emergency Contraceptive Pills Market Growth 2023-2029

Global Emergency Contraceptive Pills Market Growth 2023-2029

The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
LPI (LP Information)' newest research report, the “Emergency Contraceptive Pills Industry Forecast” looks at past sales and reviews total world Emergency Contraceptive Pills sales in 2022, providing a comprehensive analysis by region and market sector of projected Emergency Contraceptive Pills sales for 2023 through 2029. With Emergency Contraceptive Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Emergency Contraceptive Pills industry.
This Insight Report provides a comprehensive analysis of the global Emergency Contraceptive Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Emergency Contraceptive Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Emergency Contraceptive Pills market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Emergency Contraceptive Pills and breaks down the forecast by type, by distribution channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Emergency Contraceptive Pills.
The global Emergency Contraceptive Pills market size is projected to grow from US$ 517.5 million in 2022 to US$ 645.8 million in 2029; it is expected to grow at a CAGR of 645.8 from 2023 to 2029.
The major players in global Emergency Contraceptive Pills market include Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, etc. The top 3 players occupy about 55% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 75% of the global market. Levonorgestrel is the main type, with a share over 95%. Offline is the main application, which holds a share about 90%.
This report presents a comprehensive overview, market shares, and growth opportunities of Emergency Contraceptive Pills market by product type, distribution channel, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Levonorgestrel
Ulipristal Acetate
Segmentation by distribution channel
Online
Offline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Foundation Consumer Healthcare
Gedeon Richter
Zizhu Pharma
Zhejiang Xianju Pharma
HRA Pharma
Regenex
Mankind Pharma
Piramal
Lupin
Syzygy Healthcare
HLL Life Care

Key Questions Addressed in this Report
What is the 10-year outlook for the global Emergency Contraceptive Pills market?
What factors are driving Emergency Contraceptive Pills market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Emergency Contraceptive Pills market opportunities vary by end market size?
How does Emergency Contraceptive Pills break out type, distribution channel?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.